Suppr超能文献

建立客观的临床谱、基因型-表型相关性,以及作为埃利斯-范克里维尔德综合征的一个修饰因素:对[相关基因]和[相关疾病]的首次系统综述

Establishing an objective clinical spectrum, genotype-phenotype correlations, and as a modifier in the Ellis-van Creveld syndrome: The first systematic review of and -associated conditions.

作者信息

Da Silva Jorge Diogo, Soares Ana Rita, Fortuna Ana Maria, Tkachenko Nataliya

机构信息

Centro de Genética Médica Doutor Jacinto Magalhães, Centro Hospitalar Universitário de Santo António, Porto, Portugal.

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.

出版信息

Genet Med Open. 2023 Mar 13;1(1):100781. doi: 10.1016/j.gimo.2023.100781. eCollection 2023.

Abstract

PURPOSE

Ellis-van Creveld (EVC) syndrome is an autosomal recessive skeletal ciliopathy that was first identified in the Old Order Amish. Since its discovery, two causal genes have been identified, and , showing that several cases were misdiagnosed and were, in fact, other entities. Nevertheless, there has not been any adequate phenotypic characterization of molecularly defined EVC syndrome so far.

METHODS

We performed a systematic review of case reports of EVC syndrome with molecular confirmation of pathogenic variants in or . Demographic, genetic, and clinical information of patients was assessed.

RESULTS

We reviewed 725 papers and obtained 54 case reports/series that met the inclusion criteria, with a total subject sample of 310. Of these, 190 had biallelic variants, whereas 28 were affected heterozygotes. Our analysis revealed new phenotypes that have not been classically linked to the syndrome and others that have been linked but are very rare. Monoallelic symptomatic forms had less expressivity, and biallelic cases were milder if associated with and/or missense variants. Finally, we identified , a gene whose coding region partially overlaps with , as a potential genetic modifier of the severity of the EVC syndrome.

CONCLUSION

We provided the first objective clinical characterization of molecularly defined EVC syndrome and identified the first associated genetic modifier, , which had not been implicated in human disease before.

摘要

目的

埃利斯-范克里维尔德(EVC)综合征是一种常染色体隐性遗传性骨骼纤毛病,最初在旧秩序阿米什人群体中被发现。自其被发现以来,已确定了两个致病基因, 和 ,这表明有几例病例被误诊,实际上是其他病症。然而,迄今为止,尚未对分子定义的EVC综合征进行充分的表型特征描述。

方法

我们对经分子确认存在 或 致病变异的EVC综合征病例报告进行了系统综述。评估了患者的人口统计学、遗传学和临床信息。

结果

我们查阅了725篇论文,获得了54篇符合纳入标准的病例报告/系列,总样本量为310例。其中,190例有双等位基因变异,28例为杂合子患者。我们的分析揭示了一些以前未与该综合征经典关联的新表型,以及其他一些虽有关联但非常罕见的表型。单等位基因症状型的表现度较低,而双等位基因病例若与 和/或错义变异相关则症状较轻。最后,我们确定了 基因,其编码区与 部分重叠,是EVC综合征严重程度的潜在遗传修饰因子。

结论

我们首次对分子定义的EVC综合征进行了客观的临床特征描述,并确定了首个相关的遗传修饰因子 ,该因子此前未被认为与人类疾病有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/348e/11613718/4df3d6bcc72d/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验